SCHEMBL27717411

SCHEMBL27717411

NC(=O)Nc1nc2ccc(O)cc2s1

nearest known ligand 0.73

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 7/20 0.73
HSD17B1 P14061 8/20 0.68
HSD17B2 P37059 7/20 0.64
DYRK1B Q9Y463 2/20 0.64
MAOA P21397 1/20 0.63
MAOB P27338 1/20 0.63
DYRK2 Q92630 1/20 0.60
HSD17B10 Q99714 2/20 0.57
CYP3A4 P08684 1/20 0.57
CYP2D6 P10635 1/20 0.57
CYP2C9 P11712 1/20 0.57
CYP2B6 P20813 1/20 0.57
CYP2C19 P33261 1/20 0.57
SCD O00767 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL544349 0.86 DYRK1A (0.75) DYRK1AHSD17B1HSD17B2DYRK1BMAOA
SCHEMBL10170616 0.84 DYRK1A (1.00) DYRK1AHSD17B1HSD17B2DYRK1BCYP3A4
SCHEMBL19464560 0.83 HSD17B1 (0.74) DYRK1AHSD17B1HSD17B2CYP3A4CYP2D6
SCHEMBL13486495 0.83 DYRK1A (0.76) DYRK1AHSD17B10
SCHEMBL6641942 0.83 DYRK1A (0.74) DYRK1ACYP2C9CYP2C19
SCHEMBL31024 0.82 HSD17B1 (0.82) DYRK1AHSD17B1HSD17B2DYRK1BCYP3A4
SCHEMBL30522064 0.81 DYRK1A (0.68) DYRK1AHSD17B1HSD17B2DYRK1BMAOA
SCHEMBL31006 0.81 HSD17B1 (1.00) DYRK1AHSD17B1HSD17B2DYRK1BMAOA
SCHEMBL14539566 0.81 DYRK1A (0.72) DYRK1AHSD17B1HSD17B2DYRK1BMAOA
SCHEMBL1259648 0.81 MAOA (0.87) DYRK1AHSD17B1HSD17B2DYRK1BMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101273019-A Novel benzimidazole and benzothiazole derivatives, method for preparing same, use thereof as drugs, pharmaceutical compositions and novel use especially as C-Met inhibitors AVENTIS PHARMA SA (FR) 2008-09-24 CN disclosed